ARRDC3 Polymorphisms May Affect the Risk of Glioma in Chinese Han.

The Affiliated Children Hospital of Xi’an Jiaotong University,Shi Hangyu,Hou Pengfei,Gao Lu,Shi Yongqiang,Mi Weiyang,Zhang Gang,Wang Ning,Dai Wei,Wei Lin,Jin Tianbo,Shi Yongzhi,Guo Shiwen
DOI: https://doi.org/10.1007/s10142-021-00807-7
2021-01-01
Functional & Integrative Genomics
Abstract:This study ascertained to explore the potential contribution of ARRDC3 polymorphisms in the risk and prognosis of glioma. One thousand sixty-one patients and healthy controls were conducted to assess whether ARDC3 polymorphism was associated with glioma risk and prognosis. Four sites in ARRDC3 were selected and genotyped in MassARRAY platform. The calculated odd ratios and 95% confidence intervals from logistic regression were applied for risk assessment. The relationship between ARRDC3 variants and glioma prognosis was evaluated using log-rank test, Kaplan–Meier analysis, and so on. Also, false-positive report probability (FPRP) and statistical power were also assessed. Our findings suggested the negative role of ARRDC3 polymorphisms in the glioma risk. We also found the effect of candidate SNPs in ARRDC3 on the susceptibility to glioma was dependent on the age, gender, and histology of glioma patients. The results suggested that the genetic polymorphisms of ARRDC3 were related to an increased risk of glioma.
What problem does this paper attempt to address?